Logo image of NRN.CA

NORTHERN SHIELD RESOURCES IN (NRN.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:NRN - CA6657203064 - Common Stock

0.07 CAD
0 (0%)
Last: 12/30/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NRN. NRN was compared to 804 industry peers in the Metals & Mining industry. While NRN seems to be doing ok healthwise, there are quite some concerns on its profitability. NRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NRN has reported negative net income.
In the past year NRN has reported a negative cash flow from operations.
NRN had negative earnings in each of the past 5 years.
NRN had negative operating cash flow in 4 of the past 5 years.
NRN.CA Yearly Net Income VS EBIT VS OCF VS FCFNRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -20.58%, NRN perfoms like the industry average, outperforming 49.63% of the companies in the same industry.
The Return On Equity of NRN (-24.38%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -20.58%
ROE -24.38%
ROIC N/A
ROA(3y)-44.73%
ROA(5y)-29.8%
ROE(3y)-56.39%
ROE(5y)-37.05%
ROIC(3y)N/A
ROIC(5y)N/A
NRN.CA Yearly ROA, ROE, ROICNRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

NRN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRN.CA Yearly Profit, Operating, Gross MarginsNRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for NRN has been increased compared to 1 year ago.
The number of shares outstanding for NRN has been increased compared to 5 years ago.
NRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NRN.CA Yearly Shares OutstandingNRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRN.CA Yearly Total Debt VS Total AssetsNRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

NRN has an Altman-Z score of -3.73. This is a bad value and indicates that NRN is not financially healthy and even has some risk of bankruptcy.
NRN has a Altman-Z score of -3.73. This is in the lower half of the industry: NRN underperforms 68.41% of its industry peers.
There is no outstanding debt for NRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.73
ROIC/WACCN/A
WACCN/A
NRN.CA Yearly LT Debt VS Equity VS FCFNRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

NRN has a Current Ratio of 0.67. This is a bad value and indicates that NRN is not financially healthy enough and could expect problems in meeting its short term obligations.
NRN has a Current ratio of 0.67. This is in the lower half of the industry: NRN underperforms 70.02% of its industry peers.
A Quick Ratio of 0.67 indicates that NRN may have some problems paying its short term obligations.
NRN's Quick ratio of 0.67 is on the low side compared to the rest of the industry. NRN is outperformed by 67.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.67
NRN.CA Yearly Current Assets VS Current LiabilitesNRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

NRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.43%, which is quite impressive.
EPS 1Y (TTM)82.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NRN.CA Price Earnings VS Forward Price EarningsNRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRN.CA Per share dataNRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NRN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NORTHERN SHIELD RESOURCES IN

TSX-V:NRN (12/30/2025, 7:00:00 PM)

0.07

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-24 2025-11-24
Earnings (Next)04-21 2026-04-21
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.78%
Ins Owner ChangeN/A
Market Cap9.05M
Revenue(TTM)N/A
Net Income(TTM)-705.20K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.13
P/tB 3.13
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.58%
ROE -24.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-44.73%
ROA(5y)-29.8%
ROE(3y)-56.39%
ROE(5y)-37.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18603.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.67
Altman-Z -3.73
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)7642.4%
Cap/Depr(5y)7099.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.06%
OCF growth 3YN/A
OCF growth 5YN/A

NORTHERN SHIELD RESOURCES IN / NRN.CA FAQ

What is the fundamental rating for NRN stock?

ChartMill assigns a fundamental rating of 1 / 10 to NRN.CA.


What is the valuation status for NRN stock?

ChartMill assigns a valuation rating of 0 / 10 to NORTHERN SHIELD RESOURCES IN (NRN.CA). This can be considered as Overvalued.


How profitable is NORTHERN SHIELD RESOURCES IN (NRN.CA) stock?

NORTHERN SHIELD RESOURCES IN (NRN.CA) has a profitability rating of 1 / 10.


How financially healthy is NORTHERN SHIELD RESOURCES IN?

The financial health rating of NORTHERN SHIELD RESOURCES IN (NRN.CA) is 4 / 10.